County Bk Greenwood S C Com COYA 深 沪
等待开盘 09-15 09:30:00 美东时间
6.05
-0.160
-2.58%
华盛通- 最 高6.423
- 今 开6.25
- 成交量 19.01万股
- 最 低 5.78
- 昨 收 6.21
- 总市值 1.01亿
- 52周最高 10.24
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 4.65
- 委 比 -10.55%
- 总股本 1672.51万
- 历史最高 10.6899
- 量 比 1.49
- 振 幅 10.35%
- 历史最低 3.21
- 每 手 1
- 风险率 0.75%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Coya Therapeutics' Upcoming Phase 2 Clinical Trial To Evaluate Efficacy And Safety Of COYA 302 In Patients With ALS Accepted As NEALS-Affiliated Trial By NEALS Consortium
NEALS, the world's largest ALS research consortium, has selected the COYA 302 trial and it is now affiliated with NEALS as part of its mission to accelerate the development of new treatments for people living with
09-04 20:14
What's Going On With Coya Therapeutics Stock?
Shares of Coya Therapeutics are trading higher Monday morning. The company provided an update regarding the development of a new treatment for Amyotrophic Lateral Sclerosis.
08-25 21:57
HC Wainwright & Co. Reiterates Buy on Coya Therapeutics, Maintains $18 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $18 price target.
08-25 19:25
Chardan Capital Maintains Buy on Coya Therapeutics, Maintains $14 Price Target
Chardan Capital analyst Keay Nakae maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $14 price target.
08-13 22:28
Coya Therapeutics Q2 EPS $(0.36) Beats $(0.42) Estimate, Sales $163.616K Miss $940.000K Estimate
Coya Therapeutics (NASDAQ:COYA) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.42) by 13.46 percent. This is a 89.47 percent decrease over losses of $(0.19) per share from
08-12 20:05
沙特设立高端餐饮新规，拓展经济多元化路径
①沙特发布精致餐饮新规，明确设立专属营业许可和运营标准，推动高端餐饮纳入经济多元化发展路径； ②国际品牌与本土创业者共同布局，带动高端餐饮与供应链、商业地产等相关行业协同增长。
07-28 13:11
D. Boral Capital Maintains Buy on Coya Therapeutics, Maintains $18 Price Target
D. Boral Capital analyst Jason Kolbert maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $18 price target.
07-24 23:31
Lake Street Initiates Coverage On Coya Therapeutics with Buy Rating, Announces Price Target of $16
Lake Street analyst Chad Messer initiates coverage on Coya Therapeutics (NASDAQ:COYA) with a Buy rating and announces Price Target of $16.
07-09 21:51
美股大行评级 | 潜在涨幅83.3%！Robinhood获Keybanc升目标价至110美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners：维持再鼎医药(ZLAB)"跑赢大市"评级，目标价从73美元升至75美元</p> <p>• 美银证券：维持BioCryst Pharma(BCRX)"买入"评级，目标价从13美元升至15美元
07-02 09:54
Chardan Capital Maintains Buy on Coya Therapeutics, Maintains $14 Price Target
Chardan Capital analyst Keay Nakae maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $14 price target.
07-01 23:02
